Efficacy of Esomeprazole in Patients With Frequent Heartburn

Completed · Phase 3 · Has a placebo group

Conditions studied: Heartburn

In brief

This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn

Key facts

Study ID

NCT01370538

Run by

AstraZeneca

People needed

341

Starts

2011-08-01

Expected to finish

2011-10-01

Last updated by the study team

2013-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and non-pregnant ,non-lactating females 18 years or older
• Experience heartburn at least 2 days a week
• Having heartburn that has responded to heartburn medication
• Must discontinue any current heartburn medications

You may not qualify if…

• Having a history of erosive esophagitis verified by endoscopy
• Having a history of GERD which was diagnosed by a physician
• Inability to take study medication or complete the study and all study procedures
• Subjects that have required more than one 14-day course of PPI treatment within the past 4 months

Where it is running

• Research site — Mobile, Alabama, United States
• Research site — San Francisco, California, United States
• Research site — Westlake Village, California, United States
• Research site — Lexington, Kentucky, United States
• Research site — Rochester, New York, United States
• Research site — Dakota Dunes, South Dakota, United States
• Research site — Nashville, Tennessee, United States
• Research site — Austin, Texas, United States
• Research site — San Angelo, Texas, United States
• Research site — West Jordan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.